Kamada Stock Fundamentals
| KMDA Stock | ILA 2,144 22.00 1.02% |
Kamada fundamentals help investors to digest information that contributes to Kamada's financial success or failures. It also enables traders to predict the movement of Kamada Stock. The fundamental analysis module provides a way to measure Kamada's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kamada stock.
Kamada |
Kamada Company Return On Asset Analysis
Kamada's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Kamada Return On Asset | -0.0023 |
Most of Kamada's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kamada is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Kamada has a Return On Asset of -0.0023. This is 99.97% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The return on asset for all Israel stocks is 98.36% lower than that of the firm.
Kamada Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Kamada's current stock value. Our valuation model uses many indicators to compare Kamada value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kamada competition to find correlations between indicators driving Kamada's intrinsic value. More Info.Kamada is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Kamada by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Kamada's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Kamada Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kamada's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kamada could also be used in its relative valuation, which is a method of valuing Kamada by comparing valuation metrics of similar companies.Kamada is currently under evaluation in return on asset category among its peers.
Kamada Fundamentals
| Return On Equity | -0.058 | |||
| Return On Asset | -0.0023 | |||
| Profit Margin | (0.09) % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 636.38 M | |||
| Shares Outstanding | 44.8 M | |||
| Shares Owned By Insiders | 18.50 % | |||
| Shares Owned By Institutions | 32.04 % | |||
| Price To Book | 1.13 X | |||
| Price To Sales | 5.37 X | |||
| Revenue | 103.64 M | |||
| Gross Profit | 30.33 M | |||
| EBITDA | 5 M | |||
| Net Income | (2.23 M) | |||
| Cash And Equivalents | 104.55 M | |||
| Cash Per Share | 2.23 X | |||
| Total Debt | 17.41 M | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 6.86 X | |||
| Book Value Per Share | 3.93 X | |||
| Cash Flow From Operations | (8.82 M) | |||
| Earnings Per Share | (0.15) X | |||
| Target Price | 11.0 | |||
| Number Of Employees | 355 | |||
| Beta | 0.25 | |||
| Market Capitalization | 667.53 M | |||
| Total Asset | 318.67 M | |||
| Retained Earnings | (107 M) | |||
| Working Capital | 58 M | |||
| Current Asset | 85 M | |||
| Current Liabilities | 27 M | |||
| Z Score | 22.8 | |||
| Net Asset | 318.67 M |
About Kamada Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kamada's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kamada using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kamada based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Kamada Ltd. develops, produces, and markets plasma-derived protein therapeutics for orphan indications. The company was incorporated in 1990 and is headquartered in Rehovot, Israel. KAMADA operates under Drug ManufacturersSpecialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 408 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Kamada Stock
When determining whether Kamada offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kamada's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kamada Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kamada Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kamada. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Kamada Stock refer to our How to Trade Kamada Stock guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.